Sangamo Therapeutics (SGMO) Stock: Rocketing On Strong Clinical Data
Sangamo Therapeutics Inc (NASDAQ: SGMO) is making a run for the top in the market this morning, and for good reason. The company announced data from a Phase 1/2 trial that it is working on with Pfizer (PFE). The data release proved to be positive, exciting investors and sending the stock screaming for the top. … Read more